Posts

The European Medicines Agency (EMA) is recommending Novavax’s COVID-19 vaccine carry a warning of the possibility of two types of heart inflammation, an added burden for a shot that has so far failed to win wide uptake.

The European Medicines Agency on Thursday identified severe allergic reactions as potential side effects of Novavax Inc.’s COVID-19 vaccine.